If you’ve ever had that sinking feeling after seeing a high PSA, this episode is for you. PSA alone can lie — it can rise from cycling, infection, inflammation, or just aging. It’s prostate-specific, not cancer-specific.
In this episode of Outsmart Cancer, Dr. Dino Prato, founder of Envita Medical Centers, explains what’s truly next for prostate health: going beyond PSA, robotic surgery, and fear-based decisions to a modern, precision approach that treats the whole man, not just a number.
You’ll learn why the real root driver of prostate enlargement and cancer is often metabolic syndrome and insulin resistance — not testosterone. Dr. Prato walks through how to use LPIR scoring, fasting insulin, and lifestyle changes (16:8 fasting, low refined carbs, high-quality proteins, colorful plants, fermented foods) to cool inflammation and reduce risk.
From there, he introduces a new era of screening with multi-cancer early detection blood tests, MRI of the prostate, PET imaging, circulating tumor cells, and methylation scores — all before ever rushing to biopsy or surgery.
🎯 What You’ll Learn in This Episode:
• Why high PSA isn’t always cancer — and what truly raises risk
• How insulin resistance, visceral fat & inflammation drive prostate enlargement and cancer
• Why LPIR and fasting insulin testing matter more than LDL alone
• How multi-cancer blood tests, MRI, PET, CTCs & methylation beat PSA-only screening
• How 3D cone-beam, catheter-based targeting treats the prostate without major surgery
• The role of diet, tomatoes/lycopene, green tea, herbs, melatonin & sleep in prostate health
📍 Envita Medical Centers – Scottsdale, AZ
🌐 Learn more: www.envita.com
📞 Speak to a care coordinator: 866-830-4576
Disclaimer
This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.
________________________________________
Outcomes Disclaimer
The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.
You can read the full peer-reviewed study at:
https://www.scirp.org/journal/paperinformation?paperid=132493
